Effect of Nocturnal Administration of Anti-hypertensive Medications in NoN-dippers
NCT01091753 · Status: COMPLETED · Phase: PHASE4 · Type: INTERVENTIONAL · Enrollment: 28
Last updated 2010-10-08
Summary
The purpose of this study is to determine the effect of nocturnal administration of Anti-hypertensive medications in Non-dippers.
Efficacy variables.
1. ECHO
2. 24hr. horter
3. IMT
4. BUN/crea, urine analysis (microalbulinuria
5. Cardio vascular event. "
Conditions
Interventions
- DRUG
-
Valsaltan, amlodipine
nti hypertensive medication time (nocturnal administration vs morning administration
Sponsors & Collaborators
-
Yonsei University
lead OTHER
Principal Investigators
-
Dong hun Choi · professor of division of Cardiology
Study Design
- Allocation
- RANDOMIZED
- Purpose
- TREATMENT
- Masking
- NONE
Eligibility
- Min Age
- 18 Years
- Max Age
- 70 Years
- Sex
- ALL
- Healthy Volunteers
- No
Timeline & Regulatory
- Start
- 2008-03-31
- Primary Completion
- 2009-05-31
- Completion
- 2009-09-30
Countries
- South Korea
Study Locations
More Related Trials
-
Nocturnal Hypertension and Non-Dipping Blood Pressure
NCT03128177 ·Status: COMPLETED ·Phase: NA
-
Effect of Different Antihypertensive Treatment on Serum Uric Acid in Newly Diagnosed Hypertensive Patients
NCT04554069 ·Status: UNKNOWN
-
A Pilot Study of Plasma Renin Activity Guided vs Generic Combination Therapy for Hypertension
NCT01658657 ·Status: COMPLETED ·Phase: NA
-
Controlling Blood Pressure in Treatment Resistant Hypertension: A Pilot Study
NCT02167464 ·Status: COMPLETED ·Phase: NA
-
Effects of Continuous Positive Airway Pressure and Valsartan Treatments on Arterial Blood Pressure in OSAS Patients
NCT00409487 ·Status: COMPLETED ·Phase: PHASE4
-
Bedtime ACEIs/ARBs Versus Morning ACEIs/ARBs for Reverting Non-dipping Hypertension
NCT03284099 ·Status: TERMINATED ·Phase: PHASE4
-
Diurnal BP Patterns in Those at Increased Risk of CVD
NCT04522765 ·Status: RECRUITING
-
Hypertensive Urgency Treatment and Outcomes in a Northeast Thai Population
NCT03484312 ·Status: COMPLETED
-
Management of Hypertension and Multiple Risk Factors to Enhance Cardiovascular Health
NCT02972619 ·Status: UNKNOWN ·Phase: NA
-
Nijmegen Antihypertensive Management Improvement Study
NCT00457483 ·Status: COMPLETED ·Phase: PHASE4
-
The Effect of Orally Administrated Nitrate on Renal Parameters and Systemic Haemodynamics
NCT04755400 ·Status: COMPLETED ·Phase: NA
-
Renin-Angiotensin System Inhibitors and COVID-19
NCT04331574 ·Status: UNKNOWN
-
Effect of Chronotherapy on Blood Pressure - Time of Intake of Blood Pressure Lowering Drugs
NCT05322967 ·Status: RECRUITING ·Phase: NA
-
The Effects of Doxazosin and Nifedipine on Blood Pressure Variability and Uric Acid in Plasma in Hypertensive Patients
NCT02563405 ·Status: UNKNOWN ·Phase: PHASE2/PHASE3
-
Efficacy and Safety of Valsartan Plus Hydrochlorothiazide in Patients With Slight Hypertension and Target Organ Damage
NCT00687206 ·Status: COMPLETED ·Phase: PHASE4
-
Night Ambulatory Monitoring Of Blood Pressure
NCT04119518 ·Status: COMPLETED ·Phase: NA
-
Treatment of Hypertension During Sleep
NCT03457168 ·Status: RECRUITING ·Phase: NA
-
Antihypertensives in Non-cardiac Surgical Population
NCT03953872 ·Status: COMPLETED
-
Increasing Potassium Intake in Hypertensive Individuals
NCT02759367 ·Status: COMPLETED ·Phase: NA
-
Impact of Reducing Antihypertensive Treatment on Mortality in Frail Subjects With Low Systolic Blood Pressure (SBP).
NCT03453268 ·Status: COMPLETED ·Phase: NA
-
Resistant Arterial Hypertension Cohort Study
NCT01083017 ·Status: COMPLETED
-
Renin-Guided Therapeutics in the Management of Untreated, Uncontrolled, or Complicated Hypertension
NCT00684489 ·Status: COMPLETED ·Phase: NA
-
Renal Hemodynamics and Tubular Function in Patients With Obstructive Sleep Apnea and Healthy Controls
NCT00410085 ·Status: COMPLETED ·Phase: PHASE4
-
Addressing Medication Non-adherence in Patients With Poorly Controlled Hypertension Using Urine Mass Spectrometry
NCT06938633 ·Status: RECRUITING ·Phase: NA
-
Prognosis of Coronavirus Disease 2019 (COVID-19) Patients Receiving Receiving Antihypertensives
NCT04357535 ·Status: COMPLETED